SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Pingtan Marine Enterprise Ltd. (CIK 0001517130) — Sep 10, 2020

Pingtan Marine Enterprise Ltd. (CIK 0001517130)
Date: Sept. 10, 2020 · CIK: 0001517130 · Accession: 0000000000-20-008519

AI Filing Summary & Sentiment

File numbers found in text: 333-248620

Date
September 9, 2020
Author
Not clearly detected
Form
UPLOAD
Company
Pingtan Marine Enterprise Ltd. (CIK 0001517130)

Letter

United States securities and exchange commission logo September 9, 2020 Xinrong Zhuo Chief Executive Officer Pingtan Marine Enterprise Ltd. 18-19/F, Zhongshan Building A No. 154 Hudong Road Fuzhou, China 350001 Re:Pingtan Marine Enterprise Ltd. Registration Statement on Form S-3 Filed September 4, 2020 File No. 333-248620 Dear Mr. Zhuo: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at (202) 551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Yuri Mikulka, Esq.

Show Raw Text
United States securities and exchange commission logo
September 9, 2020
Xinrong Zhuo
Chief Executive Officer
Pingtan Marine Enterprise Ltd.
18-19/F, Zhongshan Building A
No. 154 Hudong Road
Fuzhou, China 350001
Re:Pingtan Marine Enterprise Ltd.
Registration Statement on Form S-3
Filed September 4, 2020
File No. 333-248620
Dear Mr. Zhuo:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Tim Buchmiller at (202) 551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Yuri Mikulka, Esq.